APA (7th ed.) Citation

Alice B. Gottlieb, Russel Burge, William N. Malatestinic, Baojin Zhu, Yunyang Zhao, Julie McCormack, . . . Joseph F. Merola. (2023). Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program. Adis, Springer Healthcare.

Chicago Style (17th ed.) Citation

Alice B. Gottlieb, Russel Burge, William N. Malatestinic, Baojin Zhu, Yunyang Zhao, Julie McCormack, Miriam Kimel, and Joseph F. Merola. Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program. Adis, Springer Healthcare, 2023.

MLA (9th ed.) Citation

Alice B. Gottlieb, et al. Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program. Adis, Springer Healthcare, 2023.